Author

Shomron Ben-Horin 1

1 Sheba Medical Center Hospital - Tel Hashomer, Ramat Gan, Israel

ARTIFICIAL INTELLIGENCE- AIDED COLONOSCOPY DOES NOT INCREASE ADENOMA DETECTION RATE IN ROUTINE CLINICAL PRACTICE

Idan Levy, Liora Bruckmayer, Eyal Klang, Shomron Ben-Horin, Uri Kopylov

AUTOMATED GRADING OF ULCER SEVERITY ON VIDEO-CAPSULE IMAGES OF CROHN'S DISEASE WITH CONVOLUTIONAL NEURAL NETWORKS

Yiftach Barash, Liran Azaria, Shelly Soffer, Reuma Yehuda Margalit, Oranit Shlomi, Shomron Ben-Horin, Abraham Eliakim, Eyal Klang, Uri Kopylov

CAN EARLY DRUG AND ANTI-INFLIXIMAB-ANTIBODY LEVELS PREDICT PRIMARY NON RESPONSE TO INFLIXIMAB THERAPY?

Haggai Bar-Yoseph, Yehuda Chowers, Nina Levhar, Limor Selinger, Uri Manor, Miri Yavzori, Ella Fudim, Orit Picard, Uri Kopylov, Abraham (Rami) Eliakim, Shomron Ben-Horin, Bella Ungar

CELLTRION - Pivotal data of subcutaneous infliximab (CELLTRION HEALTHCARE CO., LTD.)

Shomron Ben-Horin, Subrata Ghosh, Walter Reinisch

Celltrion - Therapeutic Drug Monitoring in IBD: The Value of Biosimilar Infliximab (Celltrion Healthcare)

Walter Reinisch, Shomron Ben-Horin, Nick Kennedy

COMPARISON OF COMBINATION SUBCUTANEOUS INFLIXIMAB AND AN IMMUNOMODULATOR VERSUS SUBCUTANEOUS INFLIXIMAB MONOTHERAPY: POST-HOC ANALYSIS OF A RANDOMISED CLINICAL TRIAL

Shomron Ben-Horin

COMPARISON OF COMBINATION SUBCUTANEOUS INFLIXIMAB AND AN IMMUNOMODULATOR VERSUS SUBCUTANEOUS INFLIXIMAB MONOTHERAPY: POST-HOC ANALYSIS OF A RANDOMISED CLINICAL TRIAL

Sangwook Yoon, Dong-Hyeon Kim, Fraser Cummings, Peter Irving, Geert R. D'Haens, Shomron Ben-Horin, Walter Reinisch, Byong Duk Ye, Stefan Schreiber

CORRELATION BETWEEN MAGNETIC RESONANCE ENTEROGRAPHY, CAPSULE ENDOSCOPY, FECAL CALPROTECTIN AND CRP IN PATIENTS IN CLINICAL REMISSION WITH KNOWN SMALL BOWEL CROHN’S DISEASE PRELIMINARY RESULTS FROM THE PROSPECTIVE ISRAELI IBD RESEARCH NETWORK (IIRN) STUDY.

Doron Yablecovitch, Shomron Ben-Horin, Adi Lahat, Sandra Neuman, Benjamin Avidan, Ofir Har-Noy, Nina Levhar, Abraham (Rami) Eliakim

CROSS-IMMUNOGENICITY: ANTIBODIES TO INFLIXIMAB IN REMICADE-TREATED IBD PATIENTS SIMILARLY RECOGNIZE THE BIO-SIMILAR REMSIMA

Shomron Ben-Horin, Miri Yavzori, Orit Picard, SooYoung Lee, SungHwan Kim, Yehuda Chowers

DETECTION OF ANTI-INFLIXIMAB ANTIBODIES IS IMPACTED BY ANTIBODY TITER, INFLIXIMAB LEVEL AND IGG4 ANTIBODIES: A SYSTEMATIC COMPARISON OF THREE DIFFERENT ASSAYS

Joana Afonso, Susana Lopes, Raquel Gonçalves, Paulo Caldeira, Paula Maria Vieira Santos, Maria Helena Tavares Sousa, Jaime Ramos, Ana Rita Gonçalves, Maria Paula Ministro Santos, Isadora Rosa, Ana Isabel Lourenço Vieira, Filipa Ferreira, Yehuda Chowers, Shomron Ben-Horin, Fernando Jose Magro Dias

Item 1 - 10 / 60
1
2 3 4 5 6